221
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Analysis of COVID-19 Pandemic on Supplement Usage and Its Combination with Self-Medication within the State of Arkansas

, , , , , , & ORCID Icon show all

References

  • Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206. doi:10.1111/joim.13091.
  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061–9. doi:10.1001/jama.2020.1585.
  • Bull-Otterson L, Gray EB, Budnitz DS, Strosnider HM, Schieber LZ, Courtney J, García MC, Brooks JT, Mac Kenzie WR, Gundlapalli AV, et al. Hydroxychloroquine and chloroquine prescribing patterns by provider specialty following initial reports of potential benefit for COVID-19 treatment - United States, January–June 2020. MMWR Morbidity Mortal Weekly Rep. 2020;69(35):1210–5. doi:10.15585/mmwr.mm6935a4.
  • Grebow J. Dietary supplement sales skyrocket during coronavirus pandemic. Nutr Outlook. 2020;23.
  • Nutrition CfR. Dietary Supplement usage up dramatically during pandemic, New Ipsos-CRN Survey Shows. Washington, DC, 2020.
  • Adams KK, Baker WL, Sobieraj DM. Myth busters: dietary supplements and COVID-19. Ann Pharmacother. 2020;54(8):820–6. doi:10.1177/1060028020928052.
  • Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016/j.jbi.2019.103208.
  • Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. doi:10.1016/j.jbi.2008.08.010.
  • WHO. Coronavirus prevention: symptoms; 2020. https://www.who.int/health-topics/coronavirus#tab=tab_3
  • Burke RM, Killerby ME, Newton S, Ashworth CE, Berns AL, Brennan S, Bressler JM, Bye E, Crawford R, Harduar Morano L, et al. Symptom profiles of a convenience sample of patients with COVID-19 - United States, January–April 2020. MMWR Morbidity Mortal Weekly Rep. 2020;69(28):904–8. doi:10.15585/mmwr.mm6928a2.
  • Anderson TW, Reid DB, Beaton GH. Vitamin C and the common cold: a double-blind trial. Can Med Assoc J. 1972;107:503–8.
  • Hemilä H. Vitamin C and the common cold. Br J Nutr. 1992;67(1):3–16. doi:10.1079/bjn19920004.
  • Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;2013(1):CD000980. doi: 10.1002/14651858.CD000980.pub4.
  • Annweiler G, Corvaisier M, Gautier J, Dubée V, Legrand E, Sacco G, Annweiler C. Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study. Nutrients. 2020;12(11):3377. doi:10.3390/nu12113377.
  • Ferrari D, Locatelli M. No significant association between vitamin D and COVID-19. A retrospective study from a northern Italian hospital. Int J Vitam Nutr Res. 2021;91(3-4):200–203. doi: 10.1024/0300-9831/a000687
  • Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988. doi: 10.3390/nu12040988.
  • Pérez-López FR, Chedraui P, Pilz S. Vitamin D supplementation after the menopause. Ther Adv Endocrinol Metab. 2020;11:2042018820931291. doi:10.1177/2042018820931291.
  • Raharusun P. Patterns of COVID-19 mortality and vitamin D: an Indonesian study. SSRN Electron. 2020;7:1–12.
  • Henrina J, Lim MA, Pranata R. COVID-19 and misinformation: how an infodemic fuelled the prominence of vitamin D. Br J Nutr. 2021;125(3):359–60. doi:10.1017/S0007114520002950.
  • Rubin R. Sorting out whether vitamin D deficiency raises COVID-19 risk. JAMA. 2021;325(4):329–30. doi:10.1001/jama.2020.24127.
  • Infusino F, Marazzato M, Mancone M, Fedele F, Mastroianni CM, Severino P, Ceccarelli G, Santinelli L, Cavarretta E, Marullo AGM, et al. Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: a scoping review. Nutrients. 2020;12(6):1718. doi:10.3390/nu12061718.
  • Shakoor H, Feehan J, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, Apostolopoulos V, Stojanovska L. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19? Maturitas. 2021;143:1–9. doi:10.1016/j.maturitas.2020.08.003.
  • Shakoor H, Feehan J, Mikkelsen K, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, Stojanovska L, Apostolopoulos V. Be well: a potential role for vitamin B in COVID-19. Maturitas. 2021;144:108–11. doi:10.1016/j.maturitas.2020.08.007.
  • Keil SD, Bowen R, Marschner S. Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment. Transfusion. 2016;56(12):2948–52. doi:10.1111/trf.13860.
  • Michele CA, BA, Valeria L, Teresa M, Pasquale DL, Giuseppe C, Giovanni M, Michele DP, Ernestina P, Mario B. Vitamin supplements in the Era of SARS-Cov2 pandemic. GSC Biol. and Pharm. Sci. 2020;11(2):007–19. doi:10.30574/gscbps.2020.11.2.0114.
  • Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol. 2020;92(5):479–90. doi:10.1002/jmv.25707.
  • Kumar A, Kubota Y, Chernov M, Kasuya H. Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Med Hypotheses. 2020;144:109848– doi:10.1016/j.mehy.2020.109848.
  • Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos DA, Aaseth J, et al. Zinc and respiratory tract infections: perspectives for COVID‑19 (review). Int J Mol Med. 2020;46(1):17–26. doi:10.3892/ijmm.2020.4575.
  • Finzi E. Treatment of SARS-CoV-2 with high dose oral zinc salts: a report on four patients. Int J Infect Dis. 2020;99:307–9. doi:10.1016/j.ijid.2020.06.006.
  • Walker LA, Koturbash I, Kingston R, ElSohly MA, Yates CR, Gurley BJ, Khan I. Cannabidiol (CBD) in dietary supplements: perspectives on science, safety, and potential regulatory approaches. J Diet Suppl. 2020;17(5):493–502. doi:10.1080/19390211.2020.1777244.
  • Weng J-R, Lin C-S, Lai H-C, Lin Y-P, Wang C-Y, Tsai Y-C, Wu K-C, Huang S-H, Lin C-W. Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. Virus Res. 2019;273:197767– doi:10.1016/j.virusres.2019.197767.
  • Wieland LS, Piechotta V, Feinberg T, Ludeman E, Hutton B, Kanji S, Seely D, Garritty C. Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review. BMC Complement Med Ther. 2021;21(1):112. doi:10.1186/s12906-021-03283-5.
  • Singletary K. Turmeric: potential health benefits. Nutr Today. 2020;55(1):45–56. doi:10.1097/NT.0000000000000392.
  • Babaei F, Nassiri-Asl M, Hosseinzadeh H. Curcumin (a constituent of turmeric): new treatment option against COVID-19. Food Sci Nutr. 2020;8(10):5215–27. doi:10.1002/fsn3.1858.
  • Das S, Bhowmick S, Tiwari S, Sen S. An updated systematic review of the therapeutic role of hydroxychloroquine in coronavirus disease-19 (COVID-19). Clin Drug Investig. 2020;40(7):591–601. doi:10.1007/s40261-020-00927-1.
  • Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. Jama. 2020;323(18):1824–36. doi:10.1001/jama.2020.6019.
  • Cathey L. Timeline: tracking Trump alongside scientific developments on hydroxychloroquine; 2020. https://abcnews.go.com/Health/timeline-tracking-trump-alongside-scientific-developments-hydroxychloroquine/story?id=72170553
  • Silva Borba MG, Almeida VF, Sampaio VS, et al. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study). medRxiv. 2020:2020.2004.2007.20056424.
  • Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, Weinberg P, Kirkwood J, Muse A, DeHovitz J, et al. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA. 2020;323(24):2493–502. doi:10.1001/jama.2020.8630.
  • Vaduganathan M, van Meijgaard J, Mehra MR, Joseph J, O’Donnell CJ, Warraich HJ. Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States. JAMA. 2020;323(24):2524–6. doi:10.1001/jama.2020.9184.
  • Chahin A, Dhabaan G, Buhaish A, et al. Medications and supplements prescription patterns during COVID 19 pandemic in Yemen: a questionnaire-based study. 2021.
  • Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. Jama. 2020;324(13):1330–41. doi:10.1001/jama.2020.17023.
  • Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693–704.
  • Waljee AK, Rogers MAM, Lin P, Singal AG, Stein JD, Marks RM, Ayanian JZ, Nallamothu BK. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. doi:10.1136/bmj.j1415.
  • Kullar R, Marcelin JR, Swartz TH, Piggott DA, Macias Gil R, Mathew TA, Tan T. Racial disparity of coronavirus disease 2019 in African American Communities. J Infect Dis. 2020;222(6):890–3. doi:10.1093/infdis/jiaa372.
  • Louis-Jean J, Cenat K, Njoku CV, Angelo J, Sanon D. Coronavirus (COVID-19) and racial disparities: a perspective analysis. J Racial Ethn Health Disparities. 2020;7(6):1039–45. doi:10.1007/s40615-020-00879-4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.